Table 2.
Epidemiological and pathological characteristics.
| Parameters 1 | Patients with Testicular GCT (n =229) | Stage I (n = 171) |
Stage II and III (n =57) | p-Value 2 | |
|---|---|---|---|---|---|
| Age (years) 3 | 33 (16–61) | 33 (16–61) | 32 (19–51) | 0.758 | |
| The Charlson Comorbidity Index, CCI (value) 3 | 0 (0–1) | 0 (0–2) | 0 (0–1) | 0.417 | |
| Body mass index (kg/m2) 3 | 25.4 (17.6–46.4) | 25.5 (17.9–37.00) | 25.2 (18.5–46.4) | 0.938 | |
| Parameters 1 | Patients with testicular GCT, n (%) | Stage I n (%) |
Stage II and III n (%) |
OR (95% CI) | p-value 4 |
| <30 kg/m2 | 168 (88) | 125 (88) | 43 (84) | 1.00 (reference group) | |
| >30 kg/m2 | 25 (12) | 17 (12) | 8 (16) | 1.368 (0.551–3.395) | 0.499 |
| Smoking status | |||||
| Never | 110 (55) | 87 (60) | 23 (43) | 1.00 (reference group) | |
| Ever | 88 (45) | 58 (40) | 30 (57) | 1.957 (1.035–3.698) | 0.039 * |
| Tumor size | |||||
| <4 cm | 126 (67) | 104 (75) | 22 (44) | 1.00 (reference group) | |
| >4 cm | 62 (33) | 34 (25) | 28 (56) | 3.893 (1.973–7.681) | <0.001 * |
| Multifocality | |||||
| No | 157 (83) | 107 (79) | 50 (93) | 1.00(reference group) | |
| Yes | 32 (17) | 28 (21) | 4 (7) | 0. 306 (0.102–0.919) | 0.035 * |
1 Available data; 2 Mann–Whitney U test; 3 Median (Min-Max); 4 Logistic regression, * p < 0.05; Patients were classified as obese if their body mass index (BMI) was more than 30 kg/m2, while smokers were defined as individuals who smoked daily for any 60-day interval previous to the start of the trial; GCT-germinative cell tumors; OR-crude odds ratio; CI-confidence interval.